Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.94 SEK -5.76%
Market Cap: 557.5m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Moberg Pharma AB (publ)
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Moberg Pharma AB (publ)
Research & Development Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Moberg Pharma AB (publ)
STO:MOB
Research & Development
-kr2.4m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Research & Development
-kr557.9m
CAGR 3-Years
-34%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Research & Development
-kr731.3m
CAGR 3-Years
-66%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Moberg Pharma AB (publ)'s Research & Development?
Research & Development
-2.4m SEK

Based on the financial report for Dec 31, 2023, Moberg Pharma AB (publ)'s Research & Development amounts to -2.4m SEK.

What is Moberg Pharma AB (publ)'s Research & Development growth rate?
Research & Development CAGR 3Y
26%

The average annual Research & Development growth rates for Moberg Pharma AB (publ) have been 26% over the past three years .

Back to Top